APA (7th ed.) Citation

Huang, C., & Tseng, R. Promising Remission with Reduced Bevacizumab and Pembrolizumab Dosage in a Patient with AT-rich Interaction Domain 1A Mutated Ovarian Clear-cell Carcinoma Refractory to Chemotherapy. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Huang, Cheng-Wei, and Ruo-Han Tseng. Promising Remission with Reduced Bevacizumab and Pembrolizumab Dosage in a Patient with AT-rich Interaction Domain 1A Mutated Ovarian Clear-cell Carcinoma Refractory to Chemotherapy. Wolters Kluwer Medknow Publications.

MLA (9th ed.) Citation

Huang, Cheng-Wei, and Ruo-Han Tseng. Promising Remission with Reduced Bevacizumab and Pembrolizumab Dosage in a Patient with AT-rich Interaction Domain 1A Mutated Ovarian Clear-cell Carcinoma Refractory to Chemotherapy. Wolters Kluwer Medknow Publications.